-The Indian Express This, despite it being contract-manufactured by Pune’s Serum Institute of India whose CEO Adar Poonawalla had said that the firm was making a profit even at a price of Rs 150 per dose. At Rs 600 per dose, Indians getting inoculated with Covishield at private hospitals from May 1 could end up paying the highest price in the world for this vaccine developed by the University of Oxford and...
More »SEARCH RESULT
Total Matching Records found : 30
India’s decision to liberalise vaccine sales likely to push up prices – and block access to millions -R Ramakumar
-Scroll.in Besides, by making states responsible for buying vaccines, Modi’s government has deftly deflected possible criticism for future shortages. Over the past few weeks, the second wave of Covid-19 infections and the acute shortage of vaccines had led to considerable public anger against the government. Despite being fully aware of a potential vaccine shortage, the Union government had held back permissions for new vaccines, such as the Sputnik V, to be used in...
More »How India landed in Covid vaccine mess - GS Mudur
-The Telegraph The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the...
More »First shipment of Covid vaccines from India under COVAX likely this week: WHO's Soumya Swaminathan
-PTI/ Livemint.com WHO Chief Scientist Soumya Swaminathan said many countries around the world are waiting for the distribution to happen as they have been watching vaccination programmes beginning and scaling in high-income countries Hyderabad: The first shipment from India under COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, is likely to roll out this week, WHO Chief Scientist Soumya Swaminathan said on Monday. "Not...
More »Recovery from pandemic may take years. Government must invest in welfare projects -Nishtha Tewari
-The Indian Express The current scenario is ideal for policymakers and practitioners to drive home the importance of health spending and institutional development With the first batch of anti-COVID vaccines being rolled out, the mood of the nation seems to be upbeat as it bids farewell to the pain and anguish of last year. The emergency-use approval to the vaccine developed by Oxford University and the Swedish-British pharma major AstraZeneca, manufactured in...
More »
